BrightKaire Featured in Rochester Center for Behavioral Medicine: BrightKaire with Dr. Young

In this video, Dr. Joel Young discusses BrightKaire™, NeuroKaire’s innovative blood test designed to bring precision medicine to depression treatment. He explains how the test analyzes biological signals from a patient’s blood that reflect the activity and health of brain cells, helping predict which antidepressant medications are most likely to be effective for each individual.

The conversation highlights how BrightKaire combines patient-specific biology with advanced analytics to support more informed treatment decisions early in the care journey. By reducing reliance on trial-and-error prescribing, the technology aims to help clinicians identify effective treatment options faster and improve outcomes for patients living with depression.

Dr. Young also discusses the broader promise of precision psychiatry and how tools like BrightKaire may help transform the way mental health conditions are treated in clinical practice.

👉 Read the full article

‍